Fund Manager Tries To Duck Valeant Insider Trading Claims
A hedge fund management company dug its heels into a renewed effort to ax a multibillion-dollar securities class action over Valeant Pharmaceuticals International Inc.'s massive 2016 stock drop, claiming in New...To view the full article, register now.
Already a subscriber? Click here to view full article